Last reviewed · How we verify
NCT06210958
Single- vs. Triple-Injection Techniques for Intertransverse Process Blocks in Video-Assisted Thoracoscopic Surgery: A Randomized Trial on Sensory Blockade
NA trial testing Intertransverse process block in Intertransverse Process Block in 40 participants. Completed in 1 November 2024.
31 October 2024
Quick facts
| Lead sponsor | Chiang Mai University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 40 |
| Start date | 25 January 2024 |
| Primary completion | 31 October 2024 |
| Estimated completion | 1 November 2024 |
| Sites | 1 location across Thailand |
Drugs / interventions tested
- Intertransverse process block
Conditions studied
- Intertransverse Process Block — all drugs for Intertransverse Process Block →
- Video Assisted Thoracic Surgery — all drugs for Video Assisted Thoracic Surgery →
Sponsor
Chiang Mai University
Who can join
Adults 20 to 70, any sex, with Intertransverse Process Block or Video Assisted Thoracic Surgery. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The intertransverse process block (ITPB) is an alternatives technique of regional anesthesia for thoracic surgery. However, the precise technique of ITPB remains developing. This study aims to evaluate the efficacy of ITPB injections which are single and triple injection in adult-patients undergoing video-assisted thoracoscopic surgery. The investigators hypothesize that cutaneous sensory block and perioperative pain outcomes including pain intensity and opioids consumption in patients who received triple injections of ITPB are better than that of single injection.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Single- versus Multiple-Injection Intertransverse Process Block for VATS: A Randomized Trial on Dermatomal Sensory Blockade.
Supphapipat K, Samerchua A, Leurcharusmee P, Lapisatepun P, et al · · 2025 · PMID 40978546 · DOI 10.2147/jpr.s545731
Verify or expand the search:
- PubMed search for NCT06210958
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Intertransverse process block
Trials testing the same drug.
- NCT06946290 — Intertransverse Process Block to Improve Quality of Recovery and Pain Management in Adult Cardiac Surgical Patients · NA · recruiting
- NCT06957041 — Intertransverse Process Block for Quality of Recovery Post-Open Hepatectomy · NA · not yet recruiting
- NCT05538884 — A Novel Intertransverse Plane Block: a Magnetic Resonance Imaging and Volunteer Study · NA · completed
Other recruiting trials for Intertransverse Process Block
Currently open trials in the same condition.
- NCT07335250 — Intertransverse Process Block for Postoperative Analgesia After Thoracotomy and Lobectomy · NA · recruiting
Other Chiang Mai University trials
Trials by the same sponsor.
- NCT07366775 — A Telenursing Program to Support Diabetes Self-Management · NA · active not recruiting
- NCT07032610 — Long-term Immunogenicity of L-HAV Vaccine Among Healthy Thai Children and Adolescents · not yet recruiting
- NCT06978621 — Immunogenicity and Safety of I-HAV in Healthy Thai Children and Adolescents Lacking Protective Antibody After L-HAV · Phase 3 · recruiting
- NCT06905041 — Preoperative Anemia Affected to Postoperative Outcomes in Liver Resection · not yet recruiting
- NCT07476404 — Re-bleeding in Giant Meningioma and Intraoperative Hydroxyethyl Starch (HES) Fluid Therapy · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06210958 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Chiang Mai University
- Last refreshed: 19 February 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06210958.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing